CoQ10 (Ubiquinone) vs Ubiquinol: Bioavailability & Statin Myopathy Evidence
Pharmacokinetic comparison of oxidized Ubiquinone vs reduced active Ubiquinol assessing intestinal enterocyte absorption, plasma CoQ10 elevation, and prevention of HMG-CoA reductase inhibitor (statin) myalgia.
Key Clinical Takeaways & Systematic Review Summary
Pharmacokinetic comparison of oxidized Ubiquinone vs reduced active Ubiquinol assessing intestinal enterocyte absorption, plasma CoQ10 elevation, and prevention of HMG-CoA reductase inhibitor (statin) myalgia.
- Evidence Classification: Rigorously graded under standardized Cochrane & GRADE systematic review protocols.
- Literature Benchmark Dosage: Ubiquinol: 200–300mg/day (in divided doses with meals).
- Pharmacokinetic Timing: Always administer with dietary fat (e.g. avocado, olive oil, or meals) to maximize micellar incorporation..
- Active Primary PubMed Reference: PMID 30302465 (Nutrients).
Participate in Paid Clinical Research Studies ($750–$2,200 Stipends)
Accredited medical research centers are actively enrolling qualified participants for metabolic health, incretin therapy, and longevity studies. All physician evaluations, lab panels, and investigational compounds are provided at zero cost.
Check Clinical Trial Match Eligibility →Interactive Clinical Calculators & Drug Interaction Checkers
Calculate individualized body-weight dosages, check contraindications against prescription medications, and analyze 24-hour synergy schedules using our free interactive tool suite: